The short version
- What it doesBefore any mechanism, the label — because the card above and the filed Supplement Facts panel are not describing the same product. Per one 11.9 g scoop of SynaQuell+, as filed with the NIH Dietary Supplement Label Database: riboflavin 100 mg as riboflavin 5'-phosphate sodium; magnesium 220 mg, from 132 mg of magnesium bisglycinate chelate and 88 mg of magnesium beta-hydroxybutyrate; L-leucine 1.25 g, L-isoleucine 625 mg and L-valine 625 mg; beta-hydroxybutyrate 750 mg; reduced glutathione 500 mg; nicotinamide riboside hydrogen malate 415 mg; docosahexaenoic acid 375 mg from algal oil; Meriva curcumin phytosome 250 mg; trans-resveratrol 125 mg; betaine anhydrous 85 mg; and Ubiqsome coenzyme Q10 phytosome 50 mg NIH DSLD 323088.
- Who it is forContact/collision-sport athletes and those wanting structural brain support.
- What to watchSynaQuell contains neither choline nor ginkgo, so the choline-stacking and ginkgo-clotting cautions do not apply to it. What it does carry, per scoop, is 250 mg of reduced glutathione, 207.5 mg of nicotinamide riboside, 2.5 g of branched-chain amino acids and 125 mg of DHA — count the DHA toward a total if you also take fish oil.
How Brain Impact Support works
Built around the secondary injury phase, which unfolds over days to weeks after a head impact and is the part that is theoretically modifiable. The filed formula puts 2.5 g of branched-chain amino acids and 500 mg of beta-hydroxybutyrate against the energy crisis, 125 mg of DHA against membrane damage, and reduced glutathione, a Meriva curcumin phytosome and trans-resveratrol against the oxidative and inflammatory cascade.
Read the rest of how it works
The omega-3 here is DHA alone, at a fraction of the gram doses the traumatic brain injury literature uses, and there is no creatine in it.
Brain Impact Support: serving, timing and spacing
- Suggested serving
- As directed, particularly around contact-sport seasons.
- How often
- Daily, particularly through contact-sport seasons
- When
- With food
Label servingThe serving filed on the product label: 1 scoop of Thorne SynaQuell. Read the filed label
Good to know: Support, not protection from injury — it doesn't prevent concussions; it supports the brain's nutritional foundation.
Research on Brain Impact Support4 evidence notes: clinical, correlative, theoretical
Each note sits under the kind of evidence it stands on. A thin or missing trial means nobody has run it yet, not that it doesn’t work. How the evidence tiers work
Human clinical evidence
Built on ingredients with neuroprotective/recovery evidence (omega-3 DHA, riboflavin, curcumin); developed with athlete input.
NSF Certified for Sport.
Correlative data
Repetitive head impact tracks with worse cognitive and mood outcomes in contact-sport athletes.
Theoretical / extrapolated benefits
A pioneering 'brain-support-for-impact' category — outcome trials are still early, so benefits are supportive, not curative.
Sources read for this page
- NIH DSLD 323088. Dietary Supplement Label Database record for SynaQuell + (Thorne), label ID 323088, marked off market 17 June 2025. NIH Office of Dietary Supplements
- NIH DSLD 337875. Dietary Supplement Label Database record for SynaQuell (Thorne), label ID 337875, entered 22 August 2025, on market. NIH Office of Dietary Supplements
- Oliver JM, Jones MT, et al. Effect of Docosahexaenoic Acid on a Biomarker of Head Trauma in American Football. Medicine and Science in Sports and Exercise 2016 · PMID 26765633
- Schoenen J, et al. Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial.. Neurology 1998 · PMID 9484373
- Thompson DF, Saluja HS. Prophylaxis of migraine headaches with riboflavin: A systematic review. Journal of Clinical Pharmacy and Therapeutics 2017 · PMID 28485121
- Zempleni J, et al. Pharmacokinetics of orally and intravenously administered riboflavin in healthy humans.. American Journal of Clinical Nutrition 1996 · PMID 8604671
- Martens CR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD(+) in healthy middle-aged and older adults. Nature Communications, 2018 · PMID 29599478
- Brakedal B, et al. The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease. Cell Metabolism 2022 · PMID 35235774
- Berven H, et al. NR-SAFE: a randomized, double-blind safety trial of high dose nicotinamide riboside in Parkinson's disease. Nature Communications 2023 · PMID 38016950
- Steenge GR, et al. Betaine supplementation lowers plasma homocysteine in healthy men and women. The Journal of Nutrition, 2003 · PMID 12730412
- Cuomo J, Appendino G, et al. Comparative absorption of a standardized curcuminoid mixture and its lecithin formulation. Journal of Natural Products 2011 · PMID 21413691
- Daily JW, et al. Efficacy of Turmeric Extracts and Curcumin for Alleviating the Symptoms of Joint Arthritis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Journal of Medicinal Food, 2016 · PMID 27533649
- Walle T, et al. High absorption but very low bioavailability of oral resveratrol in humans.. Drug Metabolism and Disposition 2004 · PMID 15333514
- Boocock DJ, et al. Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent.. Cancer Epidemiology, Biomarkers & Prevention 2007 · PMID 17548692
- Gliemann L, et al. Resveratrol blunts the positive effects of exercise training on cardiovascular health in aged men.. Journal of Physiology 2013 · PMID 23878368
- Sinha R, Sinha I, et al. Oral supplementation with liposomal glutathione elevates body stores of glutathione and markers of immune function. European Journal of Clinical Nutrition 2018 · PMID 28853742
- Lu SC. Glutathione synthesis. Biochimica et Biophysica Acta 2013 · PMID 22995213
- Boyle NB, et al. The Effects of Magnesium Supplementation on Subjective Anxiety and Stress-A Systematic Review. Nutrients, 2017 · PMID 28445426
Brain Impact Support, the deep readThe mechanism, cell to human, which form, how you would know
What Brain Impact Support actually does
Before any mechanism, the label — because the card above and the filed Supplement Facts panel are not describing the same product. Per one 11.9 g scoop of SynaQuell+, as filed with the NIH Dietary Supplement Label Database: riboflavin 100 mg as riboflavin 5'-phosphate sodium; magnesium 220 mg, from 132 mg of magnesium bisglycinate chelate and 88 mg of magnesium beta-hydroxybutyrate; L-leucine 1.25 g, L-isoleucine 625 mg and L-valine 625 mg; beta-hydroxybutyrate 750 mg; reduced glutathione 500 mg; nicotinamide riboside hydrogen malate 415 mg; docosahexaenoic acid 375 mg from algal oil; Meriva curcumin phytosome 250 mg; trans-resveratrol 125 mg; betaine anhydrous 85 mg; and Ubiqsome coenzyme Q10 phytosome 50 mg NIH DSLD 323088. That is the entire active formula.
Four things in it contradict the card. There is no HydroCurc — the curcumin is Meriva, a different manufacturer's phospholipid complex NIH DSLD 323088 Cuomo 2011. “Omega-3s” is DHA alone, from algae, with no EPA. The only botanical-derived actives are curcumin and resveratrol. And the card's own safety note tells the reader to watch for stacking choline sources and for ginkgo affecting clotting: this product contains neither choline nor ginkgo.
The fifth is larger. That label is off market. SynaQuell+ is recorded as withdrawn on 17 June 2025 NIH DSLD 323088. The SynaQuell currently filed as on market is a different formula at a smaller serving: riboflavin 25 mg, magnesium 59 mg entirely from magnesium beta-hydroxybutyrate with no bisglycinate, beta-hydroxybutyrate 500 mg, reduced glutathione 250 mg, nicotinamide riboside hydrogen malate 207.5 mg, DHA 125 mg, Meriva 125 mg, trans-resveratrol 125 mg, betaine anhydrous 42.5 mg, Ubiqsome 50 mg, and the same 2.5 g of branched-chain amino acids NIH DSLD 337875. Resveratrol, coenzyme Q10 and the amino acids are unchanged. Everything else was cut: nicotinamide riboside, glutathione, Meriva and betaine to half, DHA to a third, magnesium to 27%, and riboflavin to a quarter. If you bought this product on its ingredient list, the list is not the one you bought.
The mechanisms, one line each, and they are five different arguments rather than one. DHA is structural: it is the dominant long-chain polyunsaturated fatty acid of neuronal and synaptic membranes, and the animal rationale behind this product is axonal. Beta-hydroxybutyrate is a fuel: it crosses the blood-brain barrier on monocarboxylate transporters and is oxidized in place of glucose, which is the argument for ketones after a head impact, when cerebral glucose metabolism is depressed. Riboflavin is a mitochondrial flavoprotein cofactor whose clinical home is migraine prophylaxis Schoenen 1998 Thompson 2017. Nicotinamide riboside is an NAD precursor entering past the rate-limiting classical salvage enzyme Martens 2018. Betaine is one enzyme, betaine-homocysteine methyltransferase Steenge 2003. Nothing in that list is cholinergic and nothing in it is a nootropic in the usual sense.
Cell, rodent, human — and where it stops
DHA, and this is the only ingredient with a trial in the right population and the right endpoint. Eighty-one NCAA Division I American football athletes were randomized, double-blind, to 2, 4 or 6 g/day of DHA or placebo across 189 days of a season, with blood sampled at times matched to changes in contact load. Plasma DHA rose dose-dependently. Serum neurofilament light — a biomarker of axonal injury — rose more in starters, area under the curve 1,995 plus or minus 1,383 pg/mL, than in non-starters, 1,398 plus or minus 581 pg/mL, p = 0.024. Irrespective of dose, DHA likely attenuated the rise in neurofilament light, at small to moderate effect sizes of 0.4 to 0.7 by standardized magnitude-based inference Oliver 2016.
Now the arithmetic that decides this product. The lowest arm of that trial was 2,000 mg of DHA per day. The SynaQuell+ scoop carries 375 mg NIH DSLD 323088; the product currently on the market carries 125 mg NIH DSLD 337875. That is between a fifth and a sixteenth of the smallest dose that has ever been tested against this endpoint, in the sport this product was built for.
Riboflavin. Migraine prophylaxis is established at 400 mg per day Schoenen 1998 Thompson 2017. The “+” scoop has 100 mg and the current one 25 mg NIH DSLD 323088 NIH DSLD 337875. Riboflavin absorption is saturable, so a large single oral dose is only partly absorbed Zempleni 1996 — which is an argument for splitting a dose, not for taking a quarter of one.
Nicotinamide riboside. Chronic supplementation was well tolerated and raised NAD in healthy middle-aged and older adults Martens 2018; 1,000 mg/day for 30 days raised cerebral NAD in 30 newly diagnosed, treatment-naive Parkinson's patients Brakedal 2022, with a higher-dose safety trial after it Berven 2023. The scoop declares 415 mg of a hydrogen malate salt NIH DSLD 323088, and a salt weight is not a base weight.
Betaine. Six grams a day lowers plasma homocysteine in healthy men and women Steenge 2003. Eighty-five milligrams is 1.4% of that dose; 42.5 mg is 0.7% NIH DSLD 337875.
The rest, briefly. Meriva is a lecithin delivery system developed specifically because curcumin is poorly absorbed, and the comparative absorption study is what justifies its price Cuomo 2011, with the joint-symptom literature sitting on curcumin generally Daily 2016. Resveratrol has high oral absorption and very low bioavailability because it is almost completely conjugated on first pass Walle 2004 Boocock 2007. Oral glutathione's absorption is contested: the tripeptide is normally cleaved and resynthesized inside cells from cysteine Lu 2013, and the trial evidence that oral dosing can raise body stores comes from a liposomal formulation Sinha 2018 rather than the plain reduced glutathione on this label NIH DSLD 323088. Magnesium's own mood and stress literature is mixed Boyle 2017.
The obstacle, in one sentence. Not one ingredient in this product has been tested at the dose it is present at against a concussion, subconcussive-impact or recovery outcome, and the single trial that used the right population and the right biomarker used DHA alone at 2 to 6 grams Oliver 2016. NSF Certified for Sport NIH DSLD 337875 is a statement about banned substances and manufacturing control, not about efficacy.
Brain Impact Support — which form, and does it matter
Salt and complex questions are doing real work in this product, and the label resolves almost none of them.
Riboflavin 5'-phosphate sodium rather than riboflavin: the phosphate is dephosphorylated by intestinal alkaline phosphatase before absorption, so it is a solubility and taste choice for a powder rather than a bypass of anything Zempleni 1996.
Nicotinamide riboside hydrogen malate rather than the chloride used in every human trial Martens 2018 Brakedal 2022 Berven 2023: a different counter-ion means a different quantity of nicotinamide riboside inside the same declared 415 mg NIH DSLD 323088, and the label does not state the difference. Anyone comparing this to the 1,000 mg used in the Parkinson's trial is comparing one salt weight to another.
Magnesium beta-hydroxybutyrate is doing two jobs at once, supplying part of the magnesium and part of the ketone. The current formula dropped the bisglycinate chelate entirely NIH DSLD 337875, which changes both the absorption profile and the gastrointestinal tolerability of the magnesium, and reduces total magnesium from 220 mg to 59 mg.
Meriva and Ubiqsome are phytosomes, and the milligrams on the label are milligrams of the phospholipid complex, of which the active is a fraction Cuomo 2011. Two hundred and fifty milligrams of Meriva is not 250 mg of curcuminoids, and no label in this category makes that clear.
Reduced glutathione, not liposomal. The randomized evidence that oral glutathione raises body stores used a liposomal preparation Sinha 2018; this label declares plain reduced glutathione NIH DSLD 323088 NIH DSLD 337875, which is the form with the hardest absorption argument Lu 2013.
DHA from algal oil is the same molecule as fish-derived DHA with no EPA alongside it, and it is a legitimate and deliberate choice for a vegetarian athlete — but a product described as “omega-3s” that contains one omega-3 is under-describing itself NIH DSLD 323088.
And the form question to settle first: which SynaQuell is on the shelf. The card names SynaQuell+, which is off market as of 17 June 2025 NIH DSLD 323088. What is currently filed as on market is a different formula at roughly half the dose of most shared ingredients NIH DSLD 337875.
What would have to be true, and how you would know it was not
1. The omega-3 index is the honest read-out, because it is the one ingredient with a trial. It is a standardized red blood cell measurement, it is orderable, and red cell fatty acid turnover takes roughly three months — so draw it before starting and again at 12 weeks. Predict a rise of one to two percentage points on 375 mg/day of DHA and a smaller one on 125 mg, and predict that neither approaches the exposure produced by the 2 to 6 grams a day used in the football trial Oliver 2016 NIH DSLD 323088 NIH DSLD 337875.
2. Homocysteine, because two ingredients touch it. Fasting plasma homocysteine at day 0 and week 12. Betaine lowers it at 6 g/day Steenge 2003 and riboflavin is the flavin cofactor for the MTHFR enzyme. Predict no change, because 85 mg of betaine is 1.4% of the dose that moves it NIH DSLD 323088. A fall would be a genuine finding and would need a different explanation.
3. The prediction that cuts against the product. Predict that whole-blood NAD rises and that nothing you can score neurologically does. Nicotinamide riboside raises NAD reliably Martens 2018, and a biomarker that moves while the outcome does not is the characteristic failure mode of this entire shelf. If the only thing your money buys is a number in a research assay, that is worth knowing.
4. If you are a contact-sport athlete, serum neurofilament light is now clinically available, and it is the exact endpoint of the trial this product is built on Oliver 2016. Draw it pre-season and at season's end. Predict that it rises with contact load whatever you take, because it rose in every arm of that trial and the DHA effect was an attenuation of the rise, not a prevention of it.
What will fool you: the NSF Certified for Sport mark NIH DSLD 337875. It certifies that the tub contains no banned substance and that the label is accurate. It says nothing about whether the doses do anything, and it is very easy to read a quality certification as an efficacy claim.
What nobody has tested yet
Nobody has tested this formula. There is no randomized trial of SynaQuell or SynaQuell+ against placebo on any concussion, subconcussive-impact, symptom or recovery endpoint, and these thirteen declared actives have never been given together in a published study NIH DSLD 323088 NIH DSLD 337875. Every number on this page belongs to one component at a different dose.
Nobody has tested DHA below 2 g/day against neurofilament light. The dose-finding trial started at 2,000 mg and could not separate 2, 4 and 6 g Oliver 2016. Whether 375 mg does anything to an axonal injury biomarker is an open, cheap and directly relevant question, and it is the one this product most needs answered.
Nobody has measured cerebral ketone uptake from 750 mg of an oral beta-hydroxybutyrate salt. The transport biology is established; whether that quantity moves brain ketone metabolism measurably in a human has not been published, and it is an arteriovenous difference study or a PET scan.
Nobody has run the reformulation as an experiment. The market has just performed a natural halving of most of the doses NIH DSLD 323088 NIH DSLD 337875. Comparing the two products head to head on any endpoint would be the single most informative study anybody could run on this shelf, and the material for both arms already exists.
Brain Impact Support — its own safety story, not its category's
The first safety statement on this page is a correction. The card's own note asks the reader to watch for multiple choline sources stacking and for ginkgo affecting clotting. This product contains no choline and no ginkgo NIH DSLD 323088 NIH DSLD 337875. A warning about ingredients that are not in the bottle is worse than no warning, because it spends the reader's attention on the wrong risk and teaches them to skim the next one.
What the real risks are, ingredient by ingredient. Riboflavin at 100 mg is harmless and turns urine bright yellow within hours; anybody not told will think something is wrong. Magnesium at 220 mg is a laxative dose for some people, and the current formula's magnesium comes entirely from the beta-hydroxybutyrate salt NIH DSLD 337875, which is a different tolerability profile from the bisglycinate it replaced. Two and a half grams of branched-chain amino acids is a protein and nitrogen load rather than a neurological ingredient, and it belongs in a training decision rather than a brain one.
Curcumin is the ingredient with a real interaction. It has antiplatelet activity and a rare but documented hepatotoxicity signal, and it sits in a product aimed at athletes who are frequently also taking non-steroidal anti-inflammatories Cuomo 2011 Daily 2016. Anyone on an anticoagulant or antiplatelet drug should treat 250 mg of a high-absorption curcumin as an active drug rather than a spice.
Resveratrol carries an unusual and specific caution for this audience. In aged men, resveratrol supplementation blunted several of the cardiovascular adaptations that exercise training would otherwise produce Gliemann 2013. One hundred and twenty-five milligrams is a modest dose and the finding is not universally replicated, but an athlete taking a training-adaptation supplement should know that one of its ingredients has been shown to work against training adaptation.
Nicotinamide riboside has a good tolerability record at doses well above the amount here Martens 2018 Berven 2023.
The category risk is behavioral and it is the most important sentence on the page. This is sold to people who take repeated head impacts, and no supplement prevents a concussion. The card says so, and it is right. A product that makes an athlete feel protected changes behavior on the field and in the medical tent, and behavior is what actually determines head-impact exposure and how quickly an injury is reported.
Who should not take it: anyone on an anticoagulant or antiplatelet drug, because of the curcumin Cuomo 2011 Daily 2016; anyone with active liver disease; anyone pregnant, where several of these ingredients have no data; any athlete in a tested sport who has not confirmed the certification on the tub they actually bought NIH DSLD 337875; and any athlete who would take it instead of reporting a head injury.
Brain Impact Support safety basics1 point of its own, standing advice
Its own safety story
- SynaQuell contains neither choline nor ginkgo, so the choline-stacking and ginkgo-clotting cautions do not apply to it. What it does carry, per scoop, is 250 mg of reduced glutathione, 207.5 mg of nicotinamide riboside, 2.5 g of branched-chain amino acids and 125 mg of DHA — count the DHA toward a total if you also take fish oil.
Standing advice: multi-ingredient formulas
- This is one formula with several actives, and it carries the combined safety profile of everything on its panel — the risks do not average out, they add. Check the panel above against anything else you take, because the commonest way to overdose an ingredient is to meet it twice in one day under two different product names.
The same on every page it applies to.
Not medical advice. If you take prescription medication or have a diagnosed condition, check this against it with a pharmacist or doctor. Pharmacists are underused and free.
What one label serving holds13 ingredients, from the filed label
One label serving: 1 scoop of Thorne SynaQuell.
| Ingredient | Amount |
|---|---|
| L-leucine | 1.25 g |
| L-isoleucine | 625 mg |
| L-valine | 625 mg |
| Beta-hydroxybutyrate | 500 mg |
| Reduced glutathione | 250 mg |
| Nicotinamide riboside hydrogen malate | 207.5 mg |
| Meriva curcumin phytosome | 125 mg |
| trans-Resveratrol | 125 mg |
| Docosahexaenoic acid (DHA) from algal oil | 125 mg |
| Magnesium, from magnesium beta-hydroxybutyrate | 59 mg |
| Ubiqsome coenzyme Q10 phytosome | 50 mg |
| Betaine anhydrous | 42.5 mg |
| Riboflavin | 25 mg |
Not in this formula: HydroCurc, EPA, choline, ginkgo.
SynaQuell+ (DSLD 323088), the larger formula the old card described, was withdrawn 17 June 2025. THE BUY ROUTE STILL GOES THERE. Checked 2026-09-06: every SynaQuell+ filing in DSLD is off market and only the plain SynaQuell record 337875 is active, but thorne.com/products/dp/synaquell-plus is a live product page and it is the slug this site links, so the panel quoted above and the bottle a reader receives may not be the same formula. Not a dead button -- a resolvable question for Cam, who can ask Thorne which product that page now ships.
Bloodwork to run5 tests in one order, code CAMERON
The effect itself has no blood test. That is a fact about the effect, and it changes how you should judge it.
- What to watchHow long symptoms last after a knock rather than whether you get them: headache, light sensitivity and fog in the days following an impact, written against the dates. No test, blood or otherwise, tells you a brain is protected, and any product implying one exists is selling something.
- How long before it means anythingA season. There is no week-to-week read here — the ingredients are structural, the exposure is intermittent, and the fairest comparison available is this season against your memory of the last, which is weak evidence and should be held as such.
- What will fool youThe confound that matters is not measurement, it is behavior. Believing you are protected changes how you play. Taking this is never a reason to stay on the field after a head impact or to shorten a return-to-play protocol, and the page is explicit that it supports the brain's nutritional foundation rather than preventing concussion. Any suspected concussion is an immediate medical assessment, full stop.
The labs mapped to Brain Impact Support
Code CAMERON applies automatically at checkout. Draw before you start, not after: a result with nothing to compare it to answers nothing.
Brain Impact Support FAQ5 common questions
- What is Brain Impact Support?
- Thorne SynaQuell, the formula currently on the market. Per scoop the filed panel declares L-leucine 1.25 g, L-isoleucine 625 mg, L-valine 625 mg, beta-hydroxybutyrate 500 mg, reduced glutathione 250 mg, nicotinamide riboside hydrogen malate 207.5 mg, Meriva curcumin phytosome 125 mg, trans-resveratrol 125 mg, DHA 125 mg from algal oil, magnesium 59 mg, Ubiqsome coenzyme Q10 phytosome 50 mg, betaine anhydrous 42.5 mg and riboflavin 25 mg. There is no HydroCurc in it, no EPA, no choline and no ginkgo. The bigger SynaQuell+ formula was withdrawn in June 2025.
- What is the suggested dose of Brain Impact Support?
- As directed, particularly around contact-sport seasons. This is a general reference for education only. Statements have not been evaluated by the FDA and this is not medical advice.
- Who is Brain Impact Support for?
- Contact/collision-sport athletes and those wanting structural brain support.
- Which labs show whether Brain Impact Support is doing anything?
- TSH (Thyroid-Stimulating Hormone), Vitamin B12, Methylmalonic Acid (MMA), Ferritin, Vitamin D (25-Hydroxy). Draw a baseline before you start, then recheck.
- Where can I buy Brain Impact Support?
- Coach Cam sources Brain Impact Support from Thorne, with 10% off applied automatically at checkout. Use the buy link on this page.



